Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis
- 1 February 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 15 (1) , 73-78
Abstract
Purpose of review Bone regeneration and fracture repair are the complex processes of mesenchymal stem cell invasion, chondrogenesis, osteogenesis and angiogenesis. The coordinated actions of these principal processes result in the reconstruction of a normal bone and restoration of a structural unit. However, these normal bone regenerative mechanisms breakdown during fracture repair failure and postmenopausal osteoporosis. Recent findings Recent discoveries of circulating multipotent stem cells with mixed characteristics of endothelial cell and osteogenic capacity have raised interest in new and potentially breakthrough therapies for fracture and pathologic bone loss. The cooperative actions of other mesenchymal stem cell lineage such as adipocytes and processes such as angiogenesis in bone repair could also serve as novel therapeutic targets. Recent data suggest that anabolic parathyroid hormone therapy, already approved for the treatment of osteoporosis, may recruit osteoprogenitor cells and also have a role in fracture repair. Summary The present review will highlight recent information on stem cells and bone repair and examine potential avenues for future research.Keywords
This publication has 58 references indexed in Scilit:
- Role of hypoxia-inducible factor-1α in angiogenic–osteogenic couplingJournal of Molecular Medicine, 2009
- Specific Residues of RUNX2 Are Obligatory for Formation of BMP2-Induced RUNX2-SMAD Complex to Promote Osteoblast DifferentiationCells Tissues Organs, 2008
- Teriparatide (1‐34 human PTH) regulation of osterix during fracture repairJournal of Cellular Biochemistry, 2008
- Effect of age on vascularization during fracture repairJournal of Orthopaedic Research, 2008
- Structural Coupling of Smad and Runx2 for Execution of the BMP2 Osteogenic SignalJournal of Biological Chemistry, 2008
- Activation of the hypoxia-inducible factor-1α pathway accelerates bone regenerationProceedings of the National Academy of Sciences, 2008
- The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal developmentJournal of Clinical Investigation, 2007
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994